Clincosm LogoSign in Get a demo

Gastric Adenocarcinoma

Showing 26 - 50 of 167
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Adenocarcinoma Trial in Worldwide (Derazantinib, Derazantinib-paclitaxel-ramucirumab, Derazantinib-atezolizumab)

Completed
  • Gastric Adenocarcinoma
  • Orlando, Florida
  • +80 more
Jan 13, 2023

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)

Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • Chandler, Arizona
  • +65 more
Dec 19, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Japan (ASP2138)

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Santa Monica, California
  • +5 more
Dec 13, 2022

Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,

Recruiting
  • Epstein-Barr Virus Positive
  • +10 more
  • Atlanta, Georgia
  • +2 more
Dec 10, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Houston, Texas
  • +3 more
Nov 13, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Birmingham, Alabama
  • +47 more
Oct 27, 2022

Gastric Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Houston (Aerobic Exercise, Dietary Intervention, Nutritional

Withdrawn
  • Gastric Adenocarcinoma
  • Pancreatic Adenocarcinoma
  • Aerobic Exercise
  • +5 more
  • (no location specified)
Oct 26, 2022

Oesophageal Carcinoma, Gastric Adenocarcinoma Trial in France (Questionnaire)

Active, not recruiting
  • Oesophageal Carcinoma
  • Gastric Adenocarcinoma
  • Questionnaire
  • Boulogne-sur-Mer, France
  • +9 more
Oct 21, 2022

Gastric Adenocarcinoma Trial in Guangzhou (Sintilimab, Ramucirumab, Cisplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 10, 2022

Gastric Adenocarcinoma, Gastric Cancer Trial in Odense, Stockholm (Doxorubicin, Cisplatin)

Completed
  • Gastric Adenocarcinoma
  • Gastric Cancer
  • Odense, Denmark
  • +1 more
Oct 5, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (CS1001 mAb, CS1001 , Oxaliplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • CS1001 monoclonal antibody
  • +3 more
  • Beijing, China
    Beijing Cancer Hospital
Sep 27, 2022

Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,

Recruiting
  • Gastric Adenocarcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2022

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

Available
  • Esophageal Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +3 more
Aug 24, 2022

Gastric Adenocarcinoma Trial (Pembrolizumab, Cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Gastric Cancer, Gastric Adenocarcinoma Trial in Seongnam-si (Single port or reduced ports laparoscopic distal gastrectomy and D2

Recruiting
  • Gastric Cancer
  • Gastric Adenocarcinoma
  • Single port or reduced ports laparoscopic distal gastrectomy and D2 lymph node dissection
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Aug 18, 2022

Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

Terminated
  • Pancreatic Adenocarcinoma
  • +13 more
  • San Francisco, California
  • +7 more
Aug 17, 2022

Gastric Adenocarcinoma, Adenocarcinoma of the Gastroesophageal Junction, NSCLC Trial in Worldwide (Ramucirumab, Pembrolizumab)

Completed
  • Gastric Adenocarcinoma
  • +4 more
  • New Haven, Connecticut
  • +21 more
Aug 17, 2022

Gastric Adenocarcinoma, Pancreas Adenocarcinoma, Gastric Tumor Trial (PT886)

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • (no location specified)
Aug 10, 2022

Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

Recruiting
  • Advanced Solid Tumor
  • +18 more
  • PT199
  • Anti-PD-1 monoclonal antibody
  • Huntersville, North Carolina
  • +2 more
Aug 10, 2022

Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer

Recruiting
  • Gastric Cancer
  • Gastric Adenocarcinoma
    • Milan, Italy
      Fondazione IRCSS Istituto Nazionale dei Tumori
    Aug 9, 2022